Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Agarwal Website

Piyush K. Agarwal, M.D.

Selected Publications

1)  Weintraub MD, Li QQ, Agarwal PK.
Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review).
Mol Clin Oncol. 2: 656-660, 2014.
[Journal]
2)  Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, Castle EP, Dasgupta P, Ghavamian R, Guru KA, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Redorta JP, Rha KH, Richstone L, Saar M, Scherr DS, Siemer S, Stoeckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Khan MS.
Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Eur. Urol. 65: 340-7, 2014.
[Journal]
3)  Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kevin Kelly W, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS.
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States.
Urol. Oncol. 32: 637-44, 2014.
[Journal]
4)  Park JC, Citrin DE, Agarwal PK, Apolo AB.
Multimodal management of muscle-invasive bladder cancer.
Curr Probl Cancer. 38: 80-108, 2014.
[Journal]
5)  Nakrani RN, Ghosh A, Richard Lee C, Agarwal PK, Apolo AB, Cowen EW.
New facial papules in a 66-year-old woman with bladder cancer.
J. Am. Acad. Dermatol. [Epub ahead of print], 2014.
[Journal]
6)  Ghosh M, Brancato SJ, Agarwal PK, Apolo AB.
Targeted therapies in urothelial carcinoma.
Curr Opin Oncol. 26: 305-20, 2014.
[Journal]
7)  Hoang AN, Agarwal PK, Walton-Diaz A, Wood CG, Metwalli AR, Kassouf W, Brown GA, Black PC, Urbauer DL, Grossman HB, Dinney CP, Kamat AM.
Clinical Significance of Ureteral 'Skip Lesions' at the Time of Radical Cystectomy: the Md-Anderson Experience and Review of Literature.
BJU Int. [Epub ahead of print], 2013.
[Journal]
8)  Johar RS, Hayn MH, Stegemann AP, Ahmed K, Agarwal P, Balbay MD, Hemal A, Kibel AS, Muhletaler F, Nepple K, Pattaras JG, Peabody JO, Palou Redorta J, Rha K, Richstone L, Saar M, Schanne F, Scherr DS, Siemer S, Stökle M, Weizer A, Wiklund P, Wilson T, Woods M, Yuh B, Guru KA.
Complications After Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Eur. Urol. 64: 52-7, 2013.
[Journal]
9)  Kheterpal E, Sammon JD, Diaz M, Bhandari A, Trinh Q, Pokala N, Sharma P, Menon M, Agarwal PK.
Effect of metabolic syndrome on pathologic features of prostate cancer.
Urol. Oncol. 31: 1054-9, 2013.
[Journal]
10)  Marshall SJ, Hayn MH, Stegemann AP, Agarwal PK, Badani KK, Balbay MD, Dasgupta P, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Palou Redorta J, Rha K, Richstone L, Schanne F, Scherr DS, Siemer S, Stöckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Guru KA.
Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC).
BJU Int. 111: 1075-80, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/21/2014.